SCHEMBL7012510

SCHEMBL7012510

Cc1ccc(-c2c(C#N)oc3ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 2/20 0.47
▸ PDE1C Q14123 2/20 0.47
▸ MAOB P27338 2/20 0.45
▸ TNKS O95271 2/20 0.45
▸ PARP1 P09874 1/20 0.45
▸ TNKS2 Q9H2K2 1/20 0.45
▸ PARP2 Q9UGN5 1/20 0.45
▸ TP53 P04637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ RET P07949 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ ADORA2A P29274 2/20 0.41
▸ PTGS2 P35354 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11552940 0.86 ADORA2A (0.51) PDE9ATNKSPARP1TNKS2TP53
SCHEMBL9170433 0.80 PTPN1 (0.39) PDE9ATNKSLMNATSHRHTT
SCHEMBL9176674 0.80 TNKS (0.40) TNKSADORA2APTGS2HPGDSMN1; SMN2
SCHEMBL9169243 0.80 PTPN1 (0.42) PDE9ATNKSLMNAHTTADORA2A
SCHEMBL12296818 0.80 LMNA (0.59) MAOBTNKSPARP1TNKS2PARP2
SCHEMBL9176872 0.79 TNKS (0.51) TNKSLMNATSHRADORA2ANPC1
Ammonia Solution, Strong SCHEMBL4851686 0.78 LMNA (0.58) MAOBTNKSPARP1TNKS2PARP2
SCHEMBL13743032 0.77 LMNA (0.56) MAOBTNKSPARP1TNKS2PARP2
SCHEMBL9175334 0.75 TNKS (0.42) MAOBTNKSLMNAHTTHPGD
SCHEMBL10045307 0.75 MAOB (0.49) MAOBTNKSPARP1TNKS2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 — — EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 — — EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 — — US disclosed
US-5215994-A Treating or preventing hypertension or heart failure FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-01 — — US disclosed
US-5210092-A Hypotensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-11 — — US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 — — EP disclosed
EP-0480204-A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 — — EP disclosed
Send feedback